Spontaneous abortion is associated with elevated systemic C5a and reduced mRNA of complement inhibitory proteins in placenta

Spontaneous abortion in early pregnancy due to unknown reasons is a common problem. The excess complement activation and consequent placental inflammation and anti‐angiogenic milieu is emerging as an important associated factor in many pregnancy‐related complications. In the present study we sought to examine the expression of complement inhibitory proteins at the feto–maternal interface and levels of complement split products in the circulation to understand their role in spontaneous abortion. Consenting pregnant women who either underwent elective abortion due to non‐clinical reasons (n = 13) or suffered miscarriage (n = 14) were recruited for the study. Systemic levels of complement factors C3a and C5a were measured by enzyme‐linked immunosorbent assay (ELISA). Plasma C5 and C3 protein levels were examined by Western blot. Expressions of complement regulatory proteins such as CD46 and CD55 in the decidua were investigated by quantitative polymerase chain reaction (PCR) and Western blot. The median of plasma C3a level was 82·83 ng/ml and 66·17 ng/ml in elective and spontaneous abortion patients, respectively. Medians of plasma C5a levels in elective and spontaneous abortion patients were 0·96 ng/ml and 1·14 ng/ml, respectively. Only plasma C5a levels but not C3a levels showed significant elevation in spontaneous abortion patients compared to elective abortion patients. Further, there was a threefold decrease in the mRNA expressions of complement inhibitory proteins CD46 and CD55 in the decidua obtained from spontaneous abortion patients compared to that of elective abortion patients. These data suggested that dysregulated complement cascade may be associated with spontaneous abortion.

[1]  G. Sordo,et al.  Complementemia and obstetric outcome in pregnancy with antiphospholipid syndrome , 2012, Lupus.

[2]  S. le Cessie,et al.  Classical complement activation as a footprint for murine and human antiphospholipid antibody‐induced fetal loss , 2011, The Journal of pathology.

[3]  J. Atkinson,et al.  Mutations in Complement Regulatory Proteins Predispose to Preeclampsia: A Genetic Analysis of the PROMISSE Cohort , 2011, PLoS medicine.

[4]  R. Gibbs,et al.  Early Elevations of the Complement Activation Fragment C3a and Adverse Pregnancy Outcomes , 2011, Obstetrics and gynecology.

[5]  J. Gris,et al.  Analysis of genes coding for CD46, CD55, and C4b‐binding protein in patients with idiopathic, recurrent, spontaneous pregnancy loss , 2010, European journal of immunology.

[6]  I. Nilsson,et al.  Intrauterine death and circulating anticoagulant ("antithromboplastin"). , 2009, Acta medica Scandinavica.

[7]  T. Byers,et al.  Complement activation fragment Bb in early pregnancy and spontaneous preterm birth. , 2008, American journal of obstetrics and gynecology.

[8]  S. Yasuda,et al.  Complement activation in patients with primary antiphospholipid syndrome , 2008, Annals of the rheumatic diseases.

[9]  R. Gorczynski,et al.  ORIGINAL ARTICLE: LPS‐Induced Murine Abortions Require C5 but not C3, and are Prevented by Upregulating Expression of the CD200 Tolerance Signaling Molecule , 2008, American journal of reproductive immunology.

[10]  V. M. Holers,et al.  The spectrum of complement alternative pathway‐mediated diseases , 2008, Immunological reviews.

[11]  T. Byers,et al.  Alternative complement pathway activation fragment Bb in early pregnancy as a predictor of preeclampsia. , 2008, American journal of obstetrics and gynecology.

[12]  J. Shamonki,et al.  Excessive complement activation is associated with placental injury in patients with antiphospholipid antibodies. , 2007, American journal of obstetrics and gynecology.

[13]  J. Thurman,et al.  Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction , 2006, The Journal of experimental medicine.

[14]  A. Caudy,et al.  Genetic and functional analyses of membrane cofactor protein (CD46) mutations in atypical hemolytic uremic syndrome. , 2006, Journal of the American Society of Nephrology : JASN.

[15]  K. Hirschhorn,et al.  Incidence and spectrum of chromosome abnormalities in spontaneous abortions: New insights from a 12-year study , 2005, Genetics in Medicine.

[16]  R. Romero,et al.  Normal pregnancy is characterized by systemic activation of the complement system , 2004, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[17]  R. Romero,et al.  Unexplained intrauterine fetal death is accompanied by activation of complement. , 2004, Journal of perinatal medicine.

[18]  Tatsuo Yamamoto,et al.  Chromosome abnormalities identified in 347 spontaneous abortions collected in Japan , 2004, The journal of obstetrics and gynaecology research.

[19]  B. Palanca,et al.  A critical role for murine complement regulator crry in fetomaternal tolerance. , 2000, Science.

[20]  F. Plummer,et al.  The Role of Maternal Syphilis, Gonorrhoea and HIV-1 Infections in Spontaneous Abortion , 1992, International journal of STD & AIDS.

[21]  J. Atkinson,et al.  Preferential inactivation of the C5 convertase of the alternative complement pathway by factor I and membrane cofactor protein (MCP). , 1991, Molecular immunology.

[22]  T. Chard.  Frequency of implantation and early pregnancy loss in natural cycles. , 1991, Bailliere's clinical obstetrics and gynaecology.

[23]  R. Cobin,et al.  Detection of at-risk pregnancy by means of highly sensitive assays for thyroid autoantibodies. , 1990, JAMA.

[24]  P. Braude,et al.  Influence of past reproductive performance on risk of spontaneous abortion. , 1989, BMJ.

[25]  Clarice R. Weinberg,et al.  Incidence of early loss of pregnancy. , 1988, The New England journal of medicine.

[26]  Branch Dw.  Immunologic disease and fetal death. , 1987 .

[27]  S. Saarikoski,et al.  Reproductive performance of women with uterine anomalies. An evaluation of 182 cases. , 1982, Acta obstetricia et gynecologica Scandinavica.

[28]  V. Bažil,et al.  Gene for human CD59 (likely Ly-6 homologue) is located on the short arm of chromosome 11 , 2006, Immunogenetics.

[29]  A. Caudy,et al.  Genetic and Functional Analyses of Membrane Cofactor Protein ( CD 46 ) Mutations in Atypical Hemolytic Uremic Syndrome , 2006 .

[30]  J. Atkinson,et al.  Membrane cofactor protein. , 1992, Current topics in microbiology and immunology.

[31]  P. Johnson,et al.  Polymorphism of the human CD46 gene in normal individuals and in recurrent spontaneous abortion. , 1991, Human immunology.

[32]  J. Atkinson,et al.  Membrane cofactor protein (MCP or CD46): newest member of the regulators of complement activation gene cluster. , 1991, Annual review of immunology.

[33]  D. Branch.  Immunologic disease and fetal death. , 1987, Clinical obstetrics and gynecology.

[34]  L. J. Cornford-Wood.  Normal pregnancy. , 1986, Nursing.

[35]  E. Brown,et al.  Complement activation. , 1981, Immunology today.

[36]  Corrado Zanella,et al.  Incidence and Combinatorial Properties of Linear Complexes , 2008, 1304.1344.